Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
机构:[1]Department of Geriatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.[2]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.[3]Department of Neurobiology, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China.首都医科大学宣武医院[4]Center of Parkinson Disease, Beijing Institute for Brain Disorders, Beijing 100069, China.[5]Beijing Key Laboratory on Parkinson Disease, Beijing 100053, China.[6]Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.[7]Department of Physiology, Capital Medical University, Beijing 100069, China.[8]Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical University, Beijing 100069, China.[9]China National Clinical Research Center for Neurological Diseases, Beijing 100050, China.
Background: Transcranial ultrasound is a useful tool for providing the evidences for the early diagnosis and differential diagnosis of Parkinson disease (PD). However, the relationship between hyper echogenicity in substantia nigra (SN) and clinical symptoms of PD patients remains unknown, and the role of dysfunction of iron metabolism on the pathogenesis of SN hyper echogenicity is unclear. Methods: PD patients was detected by transcranial sonography and divided into with no hyper echogenicity (PDSN-) group and with hyper echogenicity (PDSN+) group. Motor symptoms (MS) and non-motor symptoms (NMS) were evaluated, and the levels of iron and related proteins in serum and cerebrospinal fluid (CSF) were detected for PD patients. Data comparison between the two groups and correlation analyses were performed. Results: PDSN+ group was significantly older, and had significantly older age of onset, more advanced Hohen-Yahr stage, higher SCOPA-AUT score and lower MoCA score than PDSN-group (P < 0.05). Compared with PDSN-group, the levels of transferrin and light-ferritin in serum and iron level in CSF were significantly elevated (P < 0.05), but ferroportin level in CSF was significantly decreased in PDSN+ group (P < 0.05). Conclusions: PD patients with hyper echogenicity in SN are older, at more advanced disease stage, have severer motor symptoms, and non-motor symptoms of cognitive impairment and autonomic dysfunction. Hyper echogenicity of SN in PD patients is related to dysfunction of iron metabolism, involving increased iron transport from peripheral system to central nervous system, reduction of intracellular iron release and excessive iron deposition in brain.
基金:
The National Key Research and Development Program of China (2016YFC1306000, 2016YFC1306300),
The National Natural Science Foundation of China (81571229, 81071015, 30770745),
The Key Project of National Natural Science Foundation of China (81030062),
The Key Project of Natural Science Foundation of Beijing, China (B) (kz201610025030),
The Key Project of Natural Science Foundation of Beijing, China (4161004, kz200910025001),
The Natural Science Foundation of Beijing, China (7082032),
National Key Basic Research Program of China (2011CB504100),
Important National Science &TechnologySpecificProjects (2011ZX09102-003-01),
National Key TechnologyResearch and Development Program of the Ministry of Science and Technology of China (2013BAI09B03),
Project of Beijing Institute for Brain Disorders(BIBD-PXM2013_014226_07_000084,
High LevelTechnical Personnel Training Project of Beijing Health System, China (2009-3-26),
Project of Construction of Innovative Teams and Teacher CareerDevelopment for Universities and Colleges Under Beijing Municipality (IDHT20140514),
Capital ClinicalCharacteristic Application Research (Z12110700100000, Z121107001012161),
Beijing Healthcare Research Project, China (JING-15-2, JING-15-3),
Excellent Personnel Training Project of Beijing, China (20071D0300400076, 2016000021469G209),
Basic-ClinicalResearchCooperationFunding of Capital MedicalUniversity, China (2015-JLPT- X04, 10JL49, 14JL15),
YouthResearchFunding, Beijing TiantanHospital, Capital MedicalUniversity, China (2014-YQN-YS-18, 2015-YQN-15, 2015-YQN-05, 2015-YQN-14, 2015-YQN-17).
第一作者机构:[1]Department of Geriatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
通讯作者:
通讯机构:[1]Department of Geriatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.[2]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.[4]Center of Parkinson Disease, Beijing Institute for Brain Disorders, Beijing 100069, China.[5]Beijing Key Laboratory on Parkinson Disease, Beijing 100053, China.[8]Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Capital Medical University, Beijing 100069, China.[9]China National Clinical Research Center for Neurological Diseases, Beijing 100050, China.
推荐引用方式(GB/T 7714):
Shu-yang Yu,Chen-jie Cao,Li-jun Zuo,et al.Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study[J].BMC NEUROLOGY.2018,18(1):9.doi:10.1186/s12883-018-1016-5.
APA:
Shu-yang Yu,Chen-jie Cao,Li-jun Zuo,Ze-jie Chen,Teng-hong Lian...&Wei Zhang.(2018).Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.BMC NEUROLOGY,18,(1)
MLA:
Shu-yang Yu,et al."Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study".BMC NEUROLOGY 18..1(2018):9